Publication: Chlorhexidine allergy: Current challenges and future prospects
| dc.contributor.author | Chiewchalermsri C. | |
| dc.contributor.author | Sompornrattanaphan M. | |
| dc.contributor.author | Wongsa C. | |
| dc.contributor.author | Thongngarm T. | |
| dc.date.accessioned | 2021-04-05T03:02:09Z | |
| dc.date.available | 2021-04-05T03:02:09Z | |
| dc.date.issued | 2020 | |
| dc.date.issuedBE | 2563 | |
| dc.description.abstract | Chlorhexidine is a synthetic bisbiguanide antiseptic and was introduced in healthcare use in 1954. Allergy to chlorhexidine has been increasingly reported particularly in the perioperative and medical procedural settings. The hypersensitivity reactions range from mild cutaneous reactions to anaphylaxis or death. There are many products and medical devices containing chlorhexidine that sometimes lack standardized labeling. With the various routes of chlorhexidine exposure, accidental or recurrent reactions in chlorhexidine-allergic patients have been reported. Therefore, we aim to review the most recent evidence in clinical manifestations, diagnostic methods, management, and preventive measures with a focus on the unique features of chlorhexidine allergy. © 2020 Chiewchalermsri et al. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.citation | Journal of Asthma and Allergy. Vol 13, (2020), p.127-133 | |
| dc.identifier.doi | 10.2147/JAA.S207980 | |
| dc.identifier.issn | 11786965 | |
| dc.identifier.other | 2-s2.0-85081897066 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14740/4975 | |
| dc.rights.holder | Scopus | |
| dc.subject.other | Antibiotic agent | |
| dc.subject.other | Antiinfective agent | |
| dc.subject.other | Chlorhexidine | |
| dc.subject.other | Disinfectant agent | |
| dc.subject.other | Immunoglobulin E | |
| dc.subject.other | Allergic reaction | |
| dc.subject.other | Allergy | |
| dc.subject.other | Anaphylaxis | |
| dc.subject.other | Angioneurotic edema | |
| dc.subject.other | Basophil activation test | |
| dc.subject.other | Contact allergy | |
| dc.subject.other | Diagnostic procedure | |
| dc.subject.other | Drug eruption | |
| dc.subject.other | Drug hypersensitivity | |
| dc.subject.other | Eczema | |
| dc.subject.other | Health care | |
| dc.subject.other | Human | |
| dc.subject.other | Hypersensitivity | |
| dc.subject.other | Intracutaneous test | |
| dc.subject.other | Patch test | |
| dc.subject.other | Prevalence | |
| dc.subject.other | Prick test | |
| dc.subject.other | Review | |
| dc.subject.other | Sensitivity and specificity | |
| dc.subject.other | Sensitization | |
| dc.subject.other | Skin allergy | |
| dc.subject.other | Skin manifestation | |
| dc.title | Chlorhexidine allergy: Current challenges and future prospects | |
| dc.type | Review | |
| dspace.entity.type | Publication | |
| swu.datasource.scopus | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081897066&doi=10.2147%2fJAA.S207980&partnerID=40&md5=fd358411556823f86b9e44ec8af2443b |
